Jump to content

Michael Geschwind

Add links
From Wikipedia, the free encyclopedia
Michael D. Geschwind
EducationAlbert Einstein College of Medicine (M.D., Ph.D.)

UCLA Medical Center (internship)
Johns Hopkins School of Medicine (residency)

UCSF Memory and Aging Center (fellowship)
OccupationProfessor of Neurology
Medical career
ProfessionProfessor
FieldNeurology
InstitutionsUCSF Memory and Aging Center
ResearchNeurodegenerative disorders

Michael D. Geschwind is a professor of neurology at the UCSF Memory and Aging Center (MAC), specializing in neurodegenerative disorders.[1]

Geschwind has published highly cited papers on rapidly progressive dementias,[2][3] prion diseases[4][5] (including Creutzfeldt–Jakob disease and Gerstmann–Sträussler–Scheinker syndrome),[6][7][8] Alzheimer disease,[9][10] and limbic and autoimmune encephalitis.[11][12] He has served as the principal investigator on studies on human prion disease and Creutzfeldt–Jakob disease.[13][1] He was guest editor for the American Academy of Neurology (AAN) Continuum Dementia edition, and was on the AAN committee for dementia criteria.[1] He has also published highly cited papers on cognitive dysfunction in movement disorders,[14][15] and serves as the director of the MAC Huntington's Disease center.[16]

Biography

[edit]

Like his brother Daniel Geschwind, Michael was inspired to study neurology by the work of Norman Geschwind, his father's cousin.[17] He majored in neurobiology in college, and obtained an M.D. and Ph.D. in neuroscience from Albert Einstein College of Medicine,[18] and went on to complete his internship at UCLA Medical Center, his residency at Johns Hopkins School of Medicine, and his fellowship at UCSF MAC. He currently holds the Michael J. Homer Chair in Neurology at UCSF MAC.[19]

He serves on the board of directors of the San Francisco Bay Area chapter of Physicians for Social Responsibility.[19]

References

[edit]
  1. ^ a b c "Michael Geschwind | UCSF Profiles". profiles.ucsf.edu. Retrieved 2018-10-04.
  2. ^ Geschwind, Michael D.; Shu, Huidy; Haman, Aissa; Sejvar, James J.; Miller, Bruce L. (July 2008). "Rapidly progressive dementia". Annals of Neurology. 64 (1): 97–108. doi:10.1002/ana.21430. ISSN 0364-5134. PMC 2647859. PMID 18668637.
  3. ^ Vitali, P.; Maccagnano, E.; Caverzasi, E.; Henry, R. G.; Haman, A.; Torres-Chae, C.; Johnson, D. Y.; Miller, B. L.; Geschwind, M. D. (2011-04-06). "Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias". Neurology. 76 (20): 1711–9. doi:10.1212/WNL.0b013e31821a4439. ISSN 0028-3878. PMC 3100134. PMID 21471469.
  4. ^ Safar, Jiri G.; Geschwind, Michael D.; Deering, Camille; Didorenko, Svetlana; Sattavat, Mamta; Sanchez, Henry; Serban, Ana; Vey, Martin; Baron, Henry (2005-03-01). "Diagnosis of human prion disease". Proceedings of the National Academy of Sciences. 102 (9): 3501–3506. Bibcode:2005PNAS..102.3501S. doi:10.1073/pnas.0409651102. ISSN 0027-8424. PMC 552933. PMID 15741275.
  5. ^ Zou, Wen-Quan; Puoti, Gianfranco; Xiao, Xiangzhu; Yuan, Jue; Qing, Liuting; Cali, Ignazio; Shimoji, Miyuki; Langeveld, Jan P.M.; Castellani, Rudy (2010-08-02). "Variably protease-sensitive prionopathy: A new sporadic disease of the prion protein". Annals of Neurology. 68 (2): 162–172. doi:10.1002/ana.22094. ISSN 0364-5134. PMC 3032610. PMID 20695009.
  6. ^ Young, Geoffrey S.; Geschwind, Michael D.; Fischbein, Nancy J.; Martindale, Jennifer L.; Henry, Roland G.; Liu, Songling; Lu, Ying; Wong, Stephen; Liu, Hong (2005-06-01). "Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease: High Sensitivity and Specificity for Diagnosis". American Journal of Neuroradiology. 26 (6): 1551–1562. ISSN 0195-6108. PMC 8149066. PMID 15956529.
  7. ^ Geschwind, Michael D.; Martindale, Jennifer; Miller, Deborah; DeArmond, Stephen J.; Uyehara-Lock, Jane; Gaskin, David; Kramer, Joel H.; Barbaro, Nicholas M.; Miller, Bruce L. (2003-06-01). "Challenging the Clinical Utility of the 14-3-3 Protein for the Diagnosis of Sporadic Creutzfeldt-Jakob Disease". Archives of Neurology. 60 (6): 813–6. doi:10.1001/archneur.60.6.813. ISSN 0003-9942. PMID 12810484.
  8. ^ Kolata, Gina Bari, 1948- (21 March 2017). Mercies in disguise : a story of hope, a family's genetic destiny, and the science that rescued them (First ed.). New York. ISBN 9781250064349. OCLC 966082972.{{cite book}}: CS1 maint: location missing publisher (link) CS1 maint: multiple names: authors list (link) CS1 maint: numeric names: authors list (link)
  9. ^ Vossel, Keith A.; Beagle, Alexander J.; Rabinovici, Gil D.; Shu, Huidy; Lee, Suzee E.; Naasan, Georges; Hegde, Manu; Cornes, Susannah B.; Henry, Maya L. (2013-09-01). "Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease". JAMA Neurology. 70 (9): 1158–66. doi:10.1001/jamaneurol.2013.136. ISSN 2168-6149. PMC 4013391. PMID 23835471.
  10. ^ Coppola, Giovanni; Chinnathambi, Subashchandrabose; Lee, Jason JiYong; Dombroski, Beth A.; Baker, Matt C.; Soto-Ortolaza, Alexandra I.; Lee, Suzee E.; Klein, Eric; Huang, Alden Y. (2012-05-03). "Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases". Human Molecular Genetics. 21 (15): 3500–3512. doi:10.1093/hmg/dds161. ISSN 0964-6906. PMC 3392107. PMID 22556362.
  11. ^ Lai, Meizan; Hughes, Ethan G.; Peng, Xiaoyu; Zhou, Lei; Gleichman, Amy J.; Shu, Huidy; Matà, Sabrina; Kremens, Daniel; Vitaliani, Roberta (April 2009). "AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location". Annals of Neurology. 65 (4): 424–434. doi:10.1002/ana.21589. ISSN 0364-5134. PMC 2677127. PMID 19338055.
  12. ^ Graus, Francesc; Titulaer, Maarten J.; Balu, Ramani; Benseler, Susanne; Bien, Christian G.; Cellucci, Tania; Cortese, Irene; Dale, Russell C.; Gelfand, Jeffrey M.; Geschwind, Michael; Glaser, Carol A.; Honnorat, Jerome; Höftberger, Romana; Iizuka, Takahiro; Irani, Sarosh R.; Lancaster, Eric; Leypoldt, Frank; Prüss, Harald; Rae-Grant, Alexander; Reindl, Markus; Rosenfeld, Myrna R.; Rostásy, Kevin; Saiz, Albert; Venkatesan, Arun; Vincent, Angela; Wandinger, Klaus-Peter; Waters, Patrick; Dalmau, Josep (2016-04-01). "A clinical approach to diagnosis of autoimmune encephalitis". The Lancet Neurology. 15 (4): 391–404. doi:10.1016/S1474-4422(15)00401-9. ISSN 1474-4422. PMC 5066574. PMID 26906964.
  13. ^ Nedelman, Michael. "A 'family curse': First insomnia, then death". CNN. Retrieved 2018-10-04.
  14. ^ Boxer, Adam L.; Geschwind, Michael D.; Belfor, Nataliya; Gorno-Tempini, Maria Luisa; Schauer, Guido F.; Miller, Bruce L.; Weiner, Michael W.; Rosen, Howard J. (2006-01-01). "Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy". Archives of Neurology. 63 (1): 81–6. doi:10.1001/archneur.63.1.81. ISSN 0003-9942. PMID 16401739.
  15. ^ Lee, J.- M.; Ramos, E. M.; Lee, J.- H.; Gillis, T.; Mysore, J. S.; Hayden, M. R.; Warby, S. C.; Morrison, P.; Nance, M. (2012-02-08). "CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion". Neurology. 78 (10): 690–695. doi:10.1212/WNL.0b013e318249f683. ISSN 0028-3878. PMC 3306163. PMID 22323755.
  16. ^ "Michael Geschwind, MD, PhD". Memory and Aging Center. Retrieved 2018-10-04.
  17. ^ Geschwind, Michael D. (29 May 2010). "Are you Related to "the Geschwind?"". Neuropsychology Review. 20 (2): 123–125. doi:10.1007/s11065-010-9135-9. ISSN 1040-7308. PMC 2881317. PMID 20512417.
  18. ^ "Health Professionals in Action: Dr. Michael Geschwind | SF Bay PSR". sfbaypsr.org. Retrieved 2018-10-04.
  19. ^ a b "Board of Directors | SF Bay PSR". sfbaypsr.org. Retrieved 2018-10-04.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Michael_Geschwind&oldid=1242873291"